Company news
uniQure N.V. news in 2021
uniQure N.V.'s news releases, calls and decks from 2021, newest first.
uniQure Announces Clinical Update on First Patients in Phase I/II Clinical Trial of AMT-130 Gene Therapy for the Treatment of Huntington’s Disease
December 15, 2021
uniQure and CSL Behring Announce Primary Endpoint Achieved in HOPE-B Pivotal Trial of Etranacogene Dezaparvovec Gene Therapy in Patients with Hemophilia B
December 8, 2021
uniQure Announces Latest Positive Recommendation from Data Safety Monitoring Board in Phase I/II Clinical Trial of AMT-130 for the Treatment of Huntington’s Disease
November 1, 2021
uniQure to Participate in Upcoming Industry Conferences in November
October 31, 2021
uniQure Announces Third Quarter 2021 Financial Results and Highlights Recent Company Progress
October 24, 2021
uniQure Announces the Appointment of Rachelle Jacques to its Board of Directors
October 20, 2021
uniQure Announces Presentations at the Annual Meeting of The European Society of Gene and Cell Therapy (ESGCT)
October 18, 2021
uniQure to Participate in Multiple Upcoming Industry Conferences in October
September 29, 2021
uniQure to Participate in Multiple Upcoming Industry Conferences in September
September 6, 2021
uniQure Announces Completion of Additional Patient Procedures Following Positive Recommendation from Data Safety Monitoring Board in Phase I/II Clinical Trial of AMT-130 for the Treatment of Huntington’s Disease
August 29, 2021
uniQure Announces Second Quarter 2021 Financial Results and Highlights Recent Company Progress
July 25, 2021
uniQure Announces Presentations at Upcoming International Society on Thrombosis and Haemostasis (ISTH) Virtual Congress
July 1, 2021
uniQure to Acquire Corlieve Therapeutics and Advance its Gene Therapy Program to Treat Temporal Lobe Epilepsy (TLE)
June 21, 2021
uniQure Announces Positive 52-Week Clinical Data from HOPE-B Pivotal Trial of Etranacogene Dezaparvovec Gene Therapy in Patients with Hemophilia B and Provides Regulatory Update
June 21, 2021
uniQure Announces Enrollment of First Two Patients in Second Cohort of Phase I/II Clinical Trial of AMT-130 for the Treatment of Huntington’s Disease
June 15, 2021
uniQure to Participate in Multiple Upcoming Industry Conferences in June
June 1, 2021
uniQure Announces Positive Recommendation to Advance Phase I/II Clinical Trial of AMT-130 for the Treatment of Huntington’s Disease
May 26, 2021
uniQure Presents HOPE-B Clinical Data Demonstrating Clinical Benefit in Hemophilia B Patients with Pre-existing Antibodies to AAV5 Vector
May 12, 2021
uniQure Announces First Quarter 2021 Financial Results and Highlights Recent Company Progress
May 9, 2021
uniQure announces closing of commercialization and license agreement with CSL Behring
May 5, 2021
uniQure to Participate in Multiple Upcoming Industry Conferences in May
May 2, 2021
uniQure Announces Presentations at Upcoming American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
April 27, 2021
uniQure Announces FDA Removes Clinical Hold on Hemophilia B Gene Therapy Program
April 25, 2021
uniQure Announces Publications of Preclinical Data for AMT-130 in Huntington’s Disease Showing Safety of Administration in NHPs and Widespread Long-Term HTT-Lowering in the Brain
April 7, 2021
uniQure Announces Completion of Enrollment in First Cohort of Phase I/II Clinical Trial of AMT-130 for the Treatment of Huntington’s Disease
April 4, 2021
uniQure to Participate in Multiple Upcoming Industry Conferences in April
March 31, 2021
uniQure Announces Findings from Reported Case of Hepatocellular Carcinoma (HCC) in Hemophilia B Gene Therapy Program
March 28, 2021
uniQure Announces 2020 Financial Results and Highlights Recent Company Progress
February 28, 2021
uniQure Announces Positive Recommendation from Data Safety Monitoring Board of Phase I/II Clinical Trial of AMT-130 for the Treatment of Huntington’s Disease
February 7, 2021
uniQure to Participate in Multiple Upcoming Industry Conferences in February
January 31, 2021
Decks in 2021
- Technical Presentation (June 2021)
Technical · 13 slides · Jun 18, 2021